Correction: Lipopolysaccharide-pretreated mesenchymal stem cell-conditioned medium optimized with 10 kDa filter attenuates the injury of H9c2 cardiomyocytes in a model of hypoxia/reoxygenation.
Can J Physiol Pharmacol
; 2022 Oct 21.
Article
in En
| MEDLINE
| ID: mdl-36268874
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Can J Physiol Pharmacol
Year:
2022
Document type:
Article
Affiliation country:
China
Country of publication:
Canadá